Overview

Study of Tocilizumab in Combination With Methotrexate for Treatment of Moderate to Severe Rheumatoid Arthritis Patients

Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
This is a Phase III study to evaluate efficacy and safety of Tocilizumab in patients with Rheumatoid Arthritis.
Phase:
Phase 3
Details
Lead Sponsor:
Chugai Pharma Taiwan
Treatments:
Methotrexate